Invention Grant
- Patent Title: Tunicamycin analogues
-
Application No.: US16619504Application Date: 2018-06-06
-
Publication No.: US10954262B2Publication Date: 2021-03-23
- Inventor: Benjamin Guy Davis , Filip Wyszynski , Hua Wang
- Applicant: Oxford University Innovation Limited
- Applicant Address: GB Oxford
- Assignee: Oxford University Innovation Limited
- Current Assignee: Oxford University Innovation Limited
- Current Assignee Address: GB Oxford
- Agency: Thomas|Horstemeyer, LLP
- Priority: GB1708982 20170606
- International Application: PCT/GB2018/051539 WO 20180606
- International Announcement: WO2018/224822 WO 20181213
- Main IPC: A01N43/04
- IPC: A01N43/04 ; A61K31/70 ; C07H19/067 ; A61P31/06
Abstract:
The invention relates to tunicamycin analogues which are compounds according to Formula (I), or pharmaceutically acceptable salts thereof, (I) Wherein [Base] and R1 to R9 are as defined herein. The tunicamycin analogues are useful in the prevention or treatment of bacterial infection, in particular of tuberculosis.
Public/Granted literature
- US20200165286A1 TUNICAMYCIN ANALOGUES Public/Granted day:2020-05-28
Information query
IPC分类:
